iCarbonX Intelligent Peptide

iCarbonX Intelligent Peptide is a specialized pharmaceutical platform operating under the umbrella of iCarbonX. The company focuses on accelerating macromolecular drug development through a combination of proprietary silicon-based peptide chip technology and artificial intelligence. By utilizing high-throughput data to train and generate advanced AI drug discovery and optimization models, the platform facilitates the precise screening of drug candidate molecules, effectively improving drug bioactivity, stability, and targeting to meet evolving clinical transformation needs.

This technology serves as a significant tool for biopharmaceutical and biotechnology partners seeking to streamline the drug research and development process. By enabling efficient large-scale detection of protein interactions, the platform helps partners move rapidly from discovery to development. The company has engaged in strategic partnerships, including collaboration with Hybio Pharmaceutical, to advance innovative drug projects such as GLP-1R/GIPR/GCGR triple agonist peptides and other oncology-focused pipeline initiatives, demonstrating its potential to deliver best-in-class solutions for the pharmaceutical industry.